Everolimus Tablet
Product Images NDC 59651-932

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 59651-932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Everolimus-figure-1 (Everolimus Fig1)

A line graph comparing estimated glomerular filtration rate (eGFR) over time between two treatment groups: EVR+Reduced TAC and TAC Control. The x-axis shows visit windows from screening to 24 months, and the y-axis displays eGFR values in mL/min/1.73 m². Both groups show a general decline in eGFR, with EVR+Reduced TAC maintaining higher values than TAC Control.*

FDA Label Image

Everolimus-figure-2 (Everolimus Fig2)

Label for Everolimus Tablets 0.25 mg oral tablets by Aurobindo Pharma USA, Inc., distributed by Aurobindo Pharma USA, Inc. The package contains 60 tablets. The label includes storage instructions, dosage directions to see package insert, and contact information for side effect reporting.*

FDA Label Image

Everolimus-fig3 (Everolimus Fig3)

Everolimus Tablets 0.5 mg oral tablet label by Aurobindo Pharma USA, Inc., distributed from India. The label indicates 60 tablets, with storage instructions and warnings to dispense the Medication Guide to patients. Includes NDC 59651-932-60 and a barcode.*

FDA Label Image

Everolimus-fig4 (Everolimus Fig4)

Everolimus Tablets 0.75 mg oral tablets label showing 60 tablets per bottle, labeled by Aurobindo Pharma Limited. The label includes storage instructions, pharmacist dispensing guidance, medication guide print link, distributor Aurobindo Pharma USA, Inc. address, and FDA side effect reporting contact.*

FDA Label Image

Everolimus-fig5 (Everolimus Fig5)

Everolimus Tablets 1 mg oral tablets packaging label from Aurobindo Pharma Limited. The label indicates the NDC number 59651-934-60 and states the package contains 60 tablets. Storage instructions specify 20° to 25°C with permitted excursions. Distributed by Aurobindo Pharma USA, Inc., made in India. Includes pharmacist dispensing instructions and FDA side effect reporting information.*

FDA Label Image

Everolimus-structure (Everolimus Str)

Chemical structure diagram of everolimus, showing its molecular arrangement with various functional groups, rings, and stereochemistry as part of the active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.